Use of antenatal corticosteroids for fetal maturation

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 2, 1996, Pages 106-109

  Gardner, Michael O ^a   Goldenberg, Robert L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

APGAR SCORE; BRAIN HEMORRHAGE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; FETUS MATURITY; HUMAN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; TREATMENT OUTCOME;

EID: 0029984686     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199604000-00004     Document Type: Review

References (37)

1. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: Efficient of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273:413-418. This article gives a complete overview of the NIH Consensus Conference with the rationale for its recommendations.
2. Bronstein JM, Goldenberg RL: Practice variation in the use of corticosteroids: a comparison of eight data sets. Am J Obstet Gynecol 1995, 173:296-298.
3. Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
4. Crowley P: Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995, 173:322-335. An update of the excellent meta-analysis reviewing the important issues concerning corticosteroids.
5. Ward RM: Pharmacologic enhancement of fetal lung maturation. Clin Perinatol 1994, 21:523-542.
6. Maher JE, Cliver SP, Goldenberg RL, Davis RO, Copper RL: The effect of corticosteroid therapy in the very premature infant Am J Obstet Gynecol 1994, 170:869-873.
7. Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, Freeman RK: A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992, 166:646-651.
8. Andrews EB, Marcucci G, White Alice, Long W: Associations between use of antenatal corticosteroids and neonatal outcomes within the Exosurf Neonatal Treatment Investigational New Drug program. Am J Obstet Gynecol 1995, 173:290-295.
9. Jobe AH, Mitchell BR, Gunkel JH: Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993, 168:508-513.
10. White A, Marcucci G, Andrews E, Edwards K, Long W: Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement Am J Obstet Gynecol 1995, 173:286-290.
11. Howie RN, Liggins GC: Clinical trial of antepartum betamethasone therapy for prevention of respiratory distress in pre-term infants. In Preterm Labor. Proceeding of the 5th Study Group of the Royal College of Obstetricians and Gynecologists. Edited by Anderson AB, et al., London: Royal College of Obstetricians and Gynecologists; 1977:281-289.
12. Kari MA, Mallman M, Eronen M, Teramo K, Virtnnen M, Koivistan M, Ikonen RS.: Prenatal steroid in conjunction with human surfactant therapy: a randomized multicenter study. Pediatrics 1994, 93:730-736.
13. Ment LR, Oh W, Ehrenkranz RA, Philip AGS, Duncan CC, Makuch RW: Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995, 172:795-800.
14. Shankaran S, Bauer CR, Bain R, Wright LL, Zachary J: Relationship between antenatal steroid administration and grades III and IV intracranial hemorrhage in low birth weight infants. Am J Obstet Gynecol 1995, 173:305-312. Demonstrates the large reduction in severe IVH associated with corticosteroid use.
15. Leviton A, Kuban KC, Pagano M, Allred EN, VanMarter LJ: Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birthweight newborns. Pediatrics 1993, 91:1083-1088.
16. Barks JDE, Post M, Tuor UI: Dexamethasone prevents hypoxicischemic brain damage in the neonatal rat Pediatr Res. 1991, 29:558-563.
17. Moise AA, Wearden ME, Welty SE, Kezinetz CA, Hansen TN: Antenatal steroids reduce the need for blood pressure support in extremely premature infants. Pediatrics 1995, 95:845-850.
18. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981, 141:276-287.
19. Morales WJ, Angel JL, Kneppel RA: Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol 1989, 73:721-726.
20. Wright LL, Horbar JD, Gunkel H, Verter J, Younes J, Andrews EB, Long W: Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995, 173:263-269. This article reviews the improvement in neonatal outcome after administration of corticosteroids. The data is from the NIH Neonatal Network and other collaborative networks.
21. Atkinson MW, Goldenberg RL, Gaudier FL, Cliver S, Nelson KG, Merkatz IR, Hauth JC: Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants. Am J Obstet Gynecol 1995, 173:299-305.
22. Horbar JD: Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol 1995, 173:275-281.
23. Howie RN: Pharmacological acceleration of lung maturation. In Respiratory distress syndrome. Edited by Villee CA, Villee DB, Zuckerman J. London: Academic Press; 1973:385-396.
24. Collaborative Group on Antenatal Steroid Therapy: Effect of antenatal steroid administration on the infant: long-term follow-up. J Pediatr 1984, 104:259-267.
25. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J: Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10 to 12 year follow-up. Pediatrics 1990, 86:65-70.
26. Goldenberg R, Gaudier F, Nelson K, Peralta M, DuBard M, Cliver S, Hauth J: The relationship of maternal and neonatal characteristics to major handicap at ≥ one year of age [Abstract]. Am J Obstet Gynecol 1994, 170:372.
27. Ohlsson A: Treatments of preterm premature rupture of membranes: a meta-analysis. Am J Obstet Gynecol 1989, 160:890-906.
28. Morales WJ, Diebel D, Lazar AJ, Zadrozny D: The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of the membranes. Am J Obstet Gynecol 1986, 154:591-595.
29. Garite TJ: The use of corticosteroids for acceleration of fetal pulmonary maturity in special clinical situations: effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Conference, National Institutes of Health, Bethesda MD., March 1994.
30. Committee on Obstetric Practice: Antenatal corticosteroid therapy for fetal maturation. ACOG Committee Opinion No. 147. American College of Obstetricians and Gynecologists, Washington DC December 1994.
31. McNamara MF, Bottons SF: No reduction in respiratory distress syndrome from repeat steroid administration [Abstract]. Am J Obstet Gynecol 1995, 172:410.
32. Bradley BS, Kumar SP, Mehta PN, Ezhuthachan SG: Neonatal cushingoid syndrome resulting from serial courses of antenatal betamethasone. Obstet Gynecol 1994, 83:869-871.
33. Gardner M, Bronstein J, Goldenberg RL, Haywood JL, Cliver SP, Nelson KG: Physician opinions of preterm infant outcome and their effect on antenatal corticosteroid use. J Perinatol 1995, in press.
34. Leviton LC, Baker S, Hassol A, Goldenberg RL: An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids. Am J Obstet Gynecol 1995, 173:312-316.
35. Simpson KN, Lynch SR, Mebane FE, Hamby TJ, Paramore C: Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants. Am J Obstet Gynecol 1995, 173:316-321.
36. Gardner M, Goldenberg RL, Gaudier F, Cliver SP, Dubard M, Hauth JC: Predicting low Apgar scores in infants weighing less than 1 kg: the effect of corticosteroids. Obstet Gynecol 1995, 85:170-174.
37. Simpson KN, Lynch SR: Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants. Am J Obstet Gynecol 1995, 173:316-321 Not only are corticosteroids effective in improving outcomes, the treatment was also shown to be highly cost-effective as well.